Salvador Nunes Luis, Greuter Thomas, Henchoz Sarah, Schoepfer Alain
Service de gastroentérologie et d'hépatologie, CHUV et Université de Lausanne, 1011 Lausanne.
Rev Med Suisse. 2021 Sep 1;17(748):1448-1452.
Inflammatory bowel diseases (IBD) comprise Crohn's disease (CD) and ulcerative colitis (UC). IBD develops in patients with genetic susceptibility due to an aberrant response of the intestinal immune system toward gut microbiota. The prevalence of IBD is on the rise in Switzerland, with currently 1/250 persons affected, which corresponds to approximately 35,000 patients. Given the complexity of IBD, patients should be managed by a multidisciplinary team. This article focuses on IBD diagnosis and long-term follow-up.
炎症性肠病（IBD）包括克罗恩病（CD）和溃疡性结肠炎（UC）。由于肠道免疫系统对肠道微生物群的异常反应，IBD在具有遗传易感性的患者中发病。瑞士IBD的患病率正在上升，目前每250人中就有1人受影响，这相当于约35000名患者。鉴于IBD的复杂性，患者应由多学科团队进行管理。本文重点关注IBD的诊断和长期随访。
